0001214659-20-000227.txt : 20200108 0001214659-20-000227.hdr.sgml : 20200108 20200108210707 ACCESSION NUMBER: 0001214659-20-000227 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20200106 FILED AS OF DATE: 20200108 DATE AS OF CHANGE: 20200108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Faga Daniel CENTRAL INDEX KEY: 0001673528 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35921 FILM NUMBER: 20516914 MAIL ADDRESS: STREET 1: 3737 MARKET STREET STREET 2: SUITE 1300 CITY: PHILADELPHIA STATE: PA ZIP: 19104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Mirati Therapeutics, Inc. CENTRAL INDEX KEY: 0001576263 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 462693615 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 858-332-3410 MAIL ADDRESS: STREET 1: 9393 TOWNE CENTRE DRIVE STREET 2: SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 4 1 marketforms-47394.xml PRIMARY DOCUMENT X0306 4 2020-01-06 0001576263 Mirati Therapeutics, Inc. MRTX 0001673528 Faga Daniel C/O MIRATI THERAPEUTICS 9393 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 false true false false EVP, Chief Operating Officer Common Stock 2020-01-06 4 A false 26240 0.00 A 26240 D Employee Stock Option (Right to Buy) 114.33 2020-01-06 4 A false 64970 0 A 2030-01-05 Common Stock 64970 64970 D Grant of Restricted Stock Units (RSUs). Shares will vest 25% annually on the anniversary of the grant date until fully vested. 25% of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of the shares subject to the Option shall vest each month thereafter until fully vested. /s/ Vickie Reed, Attorney-inFact 2020-01-08 EX-24 2 poa.htm POA DOCUMENT

      EXHIBIT 24
POWER OF ATTORNEY
	Know all by these presents, that the undersigned hereby constitutes and
appoints each of Vickie Reed and Perry Johnston or either of them signing
singly,
and with full power of substitution, the undersigned's true and lawful
attorney-in-fact to:

	(1) execute for and on behalf of the undersigned, in the undersigned's
capacity as an officer, director and/or more than 10% stockholder of Mirati
Therapeutics, Inc. (the "Company"), a Form ID, Forms 3, 4 and 5 and any other
documents necessary to facilitate the filing of reports in accordance with
Section 16(a) of the Securities Exchange Act and the rules thereunder;

	(2) do and perform any and all acts for and on behalf of the undersigned
which may be necessary or desirable to complete and execute any such Form ID or
Forms 3, 4 or 5, complete and execute any amendment or amendments thereto, and
file such forms with the SEC and any stock exchange or similar authority; and

	(3) take any other action in connection with the foregoing which, in the
opinion of such attorney-in-fact, may be of benefit to, in the best interest
of, or legally required by, the undersigned, it being understood that the
documents executed by such attorney-in-fact on behalf of the undersigned
pursuant to this Power of Attorney shall be in such form and shall contain such
terms and conditions as such attorney- in-fact may approve in such
attorney-in-fact's discretion.

	The undersigned hereby grants to each attorney-in-fact full power and
authority to do and perform any and every act and thing requisite, necessary,
or proper to be done in the exercise of any of the rights and powers herein
granted, as fully to all intents and purposes as the undersigned might or could
do if personally present, with full power of substitution or revocation, hereby
ratifying and confirming all that such attorney-in-fact, or such
attorney-in-fact's substitute or substitutes, shall lawfully do or cause to be
done by virtue of this Power of Attorney and the rights and powers herein
granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in
serving in such capacity at the request of the undersigned, are not assuming,
nor is the Company assuming, any of the undersigned's responsibilities to
comply with Section 16 of the Securities Exchange Act.

	This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 4 and 5 with respect to the
undersigned's holdings of and transactions in securities issued by the Company,
unless earlier revoked by the undersigned in a signed writing delivered to the
foregoing attorneys-in-fact.

	IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 8th day of January 2020.

/s/ Daniel Faga
Signature

Daniel Faga